Outset Medical, Inc. (NASDAQ:OM - Get Free Report) CEO Leslie Trigg sold 10,227 shares of the firm's stock in a transaction dated Tuesday, January 7th. The stock was sold at an average price of $1.29, for a total transaction of $13,192.83. Following the completion of the transaction, the chief executive officer now owns 894,624 shares in the company, valued at approximately $1,154,064.96. The trade was a 1.13 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.
Leslie Trigg also recently made the following trade(s):
- On Friday, November 15th, Leslie Trigg sold 5,645 shares of Outset Medical stock. The shares were sold at an average price of $0.80, for a total transaction of $4,516.00.
Outset Medical Stock Performance
Shares of OM opened at $1.10 on Wednesday. The firm has a fifty day moving average of $0.98 and a 200-day moving average of $1.50. The company has a market cap of $57.80 million, a price-to-earnings ratio of -0.40 and a beta of 2.05. The company has a debt-to-equity ratio of 4.12, a quick ratio of 5.04 and a current ratio of 6.49. Outset Medical, Inc. has a 1 year low of $0.44 and a 1 year high of $5.67.
Institutional Inflows and Outflows
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
From Weiss Ratings | Ad
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide.
It will give them unprecedented powers to control your bank account.
Learn these 4 simple steps and protect your savings before it’s too late.
Hedge funds and other institutional investors have recently bought and sold shares of the company. Vanguard Personalized Indexing Management LLC acquired a new position in Outset Medical during the 2nd quarter worth $49,000. Ground Swell Capital LLC acquired a new stake in Outset Medical in the second quarter worth about $49,000. Huntington National Bank lifted its holdings in Outset Medical by 46.2% in the third quarter. Huntington National Bank now owns 63,306 shares of the company's stock worth $43,000 after purchasing an additional 20,000 shares during the period. National Bank of Canada FI increased its stake in Outset Medical by 79.2% during the 3rd quarter. National Bank of Canada FI now owns 52,407 shares of the company's stock valued at $35,000 after buying an additional 23,164 shares during the period. Finally, Squarepoint Ops LLC increased its stake in Outset Medical by 74.1% during the 2nd quarter. Squarepoint Ops LLC now owns 80,300 shares of the company's stock valued at $309,000 after buying an additional 34,187 shares during the period.
Analysts Set New Price Targets
Separately, Royal Bank of Canada reaffirmed a "sector perform" rating and set a $3.00 target price on shares of Outset Medical in a report on Tuesday.
Check Out Our Latest Research Report on OM
Outset Medical Company Profile
(
Get Free Report)
Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
